These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31413211)

  • 1. [Overexpression of the long non-coding RNA ADAMTS9-AS2 suppresses colorectal cancer proliferation and metastasis].
    Bu X; Qin A; Luo Z; Hu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):741-748. PubMed ID: 31413211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer.
    Chen W; Tu Q; Yu L; Xu Y; Yu G; Jia B; Cheng Y; Wang Y
    Hum Cell; 2020 Oct; 33(4):1133-1141. PubMed ID: 32918700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
    Shi YF; Lu H; Wang HB
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis.
    Xu W; Wang B; Cai Y; Chen J; Lv X; Guo C; Yuan C
    Curr Pharm Des; 2021; 27(23):2722-2727. PubMed ID: 33823762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.
    Yu Q; Guo K; Yang Y; Liu H; Huang Y; Li W
    J Periodontal Res; 2024 Feb; 59(1):174-186. PubMed ID: 37957805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
    Chen Z; Tang W; Ye W; Song L; Chen Z
    Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
    Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
    Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melittin inhibits the proliferation migration and invasion of HCC cells by regulating ADAMTS9-AS2 demethylation.
    Lv C; Chen J; Huang F; Fang F; Li B
    Toxicon; 2023 Jan; 222():106996. PubMed ID: 36535531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
    Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
    J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
    Yao J; Zhou B; Zhang J; Geng P; Liu K; Zhu Y; Zhu W
    Tumour Biol; 2014 Aug; 35(8):7935-44. PubMed ID: 24833086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation.
    Liu D; Wu K; Yang Y; Zhu D; Zhang C; Zhao S
    Mol Carcinog; 2020 Jan; 59(1):32-44. PubMed ID: 31621118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ADAMTS9-AS2 inhibits liver cancer cell proliferation, migration and invasion.
    Li H; Huang H; Li S; Mei H; Cao T; Lu Q
    Exp Ther Med; 2021 Jun; 21(6):559. PubMed ID: 33850531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
    Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
    J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Chain Noncoding RNA ADAMTS9-AS2 Regulates Proliferation, Migration, and Apoptosis in Bladder Cancer Cells Through Regulating miR-182-5p.
    Guo Q; Ni P; Dai Y; Hu J; Yao Y
    J Interferon Cytokine Res; 2021 Feb; 41(2):60-71. PubMed ID: 33621133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.